Abbott will take on Edwards Lifesciences and Medtronic in the US transcatheter aortic valve replacement (TAVR) market with the Portico self-expanding valve with the FlexNav delivery system.
The US Food and Drug Administration approved Portico with FlexNav to treat people with symptomatic, severe aortic stenosis whose...






